Display Settings:

Format

Send to:

Choose Destination
JPEN J Parenter Enteral Nutr. 2013 Sep 26;38(5):567-575. [Epub ahead of print]

Elderly Persons With ICU-Acquired Weakness: The Potential Role for β-Hydroxy-β-Methylbutyrate (HMB) Supplementation?

Author information

  • 1Department of Medicine, Division of Gastroenterology, Western University, London, Ontario, Canada Adam.Rahman@sjhc.london.on.ca.
  • 2Department of Kinesiology and Community Health College of Applied Health Sciences, University of Illinois, Urbana-Champaign, Illinois.
  • 3Division of Nutritional Sciences, University of Illinois, Urbana-Champaign, Illinois.
  • 4Department of Medicine, University of Toronto, Toronto, Canada Department of Nutritional Sciences, University of Toronto, Toronto, Canada Department of Physiology, University of Toronto, Toronto, Canada.
  • 5Department of Anesthesia, Critical Care Medicine Section, Wake University School of Medicine, Winston-Salem, North Carolina.
  • 6Department of Surgery (General Surgery), Queen's University, Kingston, Ontario, Canada Critical Care Program, Queen's University, Kingston, Ontario, Canada.
  • 7Department of Kinesiology, University of Waterloo, Waterloo, Ontario, Canada.

Abstract

Intensive care unit (ICU)-acquired weakness is common and characterized by muscle loss, weakness, and paralysis. It is associated with poor short-term outcomes, including increased mortality, but the consequences of reduced long-term outcomes, including decreased physical function and quality of life, can be just as devastating. ICU-acquired weakness is particularly relevant to elderly patients who are increasingly consuming ICU resources and are at increased risk for ICU-acquired weakness and complications, including mortality. Elderly patients often enter critical illness with reduced muscle mass and function and are also at increased risk for accelerated disuse atrophy with acute illness. Increasingly, intensivists and researchers are focusing on strategies and therapies aimed at improving long-term neuromuscular function. β-Hydroxy-β-methylbutyrate (HMB), an ergogenic supplement, has shown efficacy in elderly patients and certain clinical populations in counteracting muscle loss. The present review discusses ICU-acquired weakness, as well as the unique physiology of muscle loss and skeletal muscle function in elderly patients, and then summarizes the evidence for HMB in elderly patients and in clinical populations. We subsequently postulate on the potential role and strategies in studying HMB in elderly ICU patients to improve muscle mass and function.

© 2013 American Society for Parenteral and Enteral Nutrition.

KEYWORDS:

adult; critical care; nutrition

PMID:
24072740
[PubMed - as supplied by publisher]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk